2025 Agenda
Monday, October 13
Time
Event
8:00 am – Lobby Level
Registration Opens
9:45 am – 2nd Floor
Welcome Remarks
- Sara Jane Demy, Founder & CEO, Demy-Colton
10:00 am – 2nd Floor
Big Think Fireside Chat
Biopharma: What the Future Looks Like
- James Flynn, Managing Partner, Deerfield
Interviewed by:
- Sara Jane Demy, Founder & CEO, Demy-Colton
11:00 am – Ground Floor,
Event Hall South
One-to-One Meetings
11:00 am – 2nd Floor
Spotlight Panel 1A
Beyond the Cure: The Brave New World of Revolutionary Cancer Therapeutics
Moderator:
- Erkang Ai, Counsel, Global Regulatory, Hogan Lovells
Panel:
- Gerald Commissiong, CBO, OS Therapies, Inc.
- Richard Kornbluth, President & CSO, Multimeric Biotherapeutics, Inc.
- Julie O’Shaughnessy, COO, Vivodyne
- Daniel Teper, CEO, Naya Therapeutics
11:00 am – 12th Floor
Spotlight Panel 1B
Rewiring Minds: Breakthroughs in Brain & CNS Health
Moderator:
- Ginger Johnson, SVP, Lumanity
Panel:
- Connor Glass, CEO & Founder, Phantom Neuro
- Beth Hoffman, CEO, Origami Therapeutics, Inc.
- Adam Rogers, CEO, NervGen Pharma
- Arun Swaminathan, CEO, Coya Therapeutics, Inc.
- Brent Vaughan, CEO & Founder, Eratos Therapeutics
12:00 pm – Ground Floor,
Event Hall South
Lunch
1:00 pm – 2nd Floor
Dialogue 1A
Rare Disease Therapies: Challenges in Development and Regulatory Pathways
Moderator:
- Chris Vlahos, VP, External Innovation, Acadia Pharmaceuticals
Panel:
- Shelley Hartman, CEO, Aegle Therapeutics Corporation
- Jennifer Schranz, SVP, Global Head, Rare Diseases, Ipsen
- Melindah Sharma, Managing Director, Commercialization, Supply Chain & Venture Capital, Manatt Health
- Rachel Sher, Life Sciences & FDA Partner, Manatt Health
2:00 pm – Ground Floor,
Event Hall South
One-to-One Meetings
2:00 pm – 2nd Floor
Spotlight Panel 2A
Where Code Meets Cells: Forging the TechBio Future
Moderator:
- Sebastien Latapie, Partner, Avant Bio
Panel:
- Bigyan Bista, SVP & Head of Business Development, Enveda
- Milad Dagher, CEO & Co-Founder, Nomic Bio
- Dan Que Pham, Co-Founder & COO, Oncodea
- Irene Rombel, CEO, President & Co-Founder, BioCurie
- Ignacio Willats, Co-Founder & CCO, Mytos
3:10 pm – 2nd Floor
Spotlight Panel 3A
Immunity Unleashed: Next-Gen Therapies & Immune Engineering
Moderator:
- Melindah Sharma, Managing Director, Commercialization, Supply Chain & Venture Capital, Manatt Health
Panel:
- Robert Arch, President, Immunophotonics, Inc.
- Frank Bedu-Addo, President & CEO, PDS Biotechnology Corporation
- Michael Montgomery, CMO & Co-Founder, Tidewave Bio
- Wenzhi Tian, CEO, ImmuneOnco Biopharmaceuticals (Shanghai) Inc.
- Ming-Ru Wu, Co-Founder, TroGen Therapeutics
3:10 pm – 12th Floor
Spotlight Panel 3B
Healthspan Horizons: Advancing Longevity Therapeutics
Moderator:
- Komal Bajaj, Chief Quality Officer, NYC Health + Hospital (Jacobi/NCB)
Panel:
- Thomas Ichim, President & CSO, Immorta Bio
- Marc Jones, CEO, Altoida, Inc.
- Hans Keirstead, Chairman, Immunis, Inc.
- Shreefāl Mehta, Co-Founder & CBO, Repoxegen Therapeutics Inc.
4:15 pm – 2nd Floor
End of Day “Big Think" Plenary Session
The Great Biopharma Reset: Will Today’s Challenging Environment Result in a more Resilient Sector?
Moderator:
- Dennis Purcell, Founder & Senior Advisor, Aisling Capital
Panel:
- Jo Natauri, Founder & Managing Partner, Invidia Capital Management
- Umer Raffat, Equity Research, Evercore ISI
- Philip Ross, Vice Chairman, Global Healthcare Investment Banking, Jefferies LLC
- Eric Schmidt, Biotechnology Analyst, Cantor Fitzgerald
5:30 pm – Location TBA
Networking Reception
Sponsored by EisnerAmper